Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- CORPORATE ROUNDUP NEWS IN BRIEF
September 17, 2001
- DIAGNOSTIC NEWS IN BRIEF
September 17, 2001
- Healthcare Reform: 30% Copayment for the Insured to Be Focused on
September 17, 2001
- Thorough Quality Control for Imported Medical Devices Called For by PMSB
September 17, 2001
- Hodanren Opposes Raising the Age Limit to 75 for Elderly Healthcare Services
September 17, 2001
- PMSB Budget Related to Medical Devices Focuses on Quality, Prioritization of Review
September 17, 2001
- 3 New Drugs Including Biapenem Recommended for Approval
September 17, 2001
- Enforcement of US/EC MRA Expected to Be Delayed: FDA Officer
September 17, 2001
- NDA Data Disclosure Procedures Notified
September 17, 2001
- MEDICAL DEVICE NEWS IN BRIEF
September 17, 2001
- JETRO Looks Into Social Security Systems in Major Countries
September 17, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
September 17, 2001
- REGULATORY NEWS IN BRIEF -1-
September 17, 2001
- Club Atmosphere in Contributing to Industry People: Mr Kodama of Pharma Delegates
September 17, 2001
- REGULATORY NEWS IN BRIEF -2-
September 17, 2001
- We Are Sure to Reach \100 Billion by Boosting Sales of Bonalon, Onealfa: Dr Naruchi of Teijin
September 17, 2001
- Dementia to Affect 10% of Elderly Citizens in 2036: Expert
September 17, 2001
- PhRMA Proposes Actual Transaction Price Reimbursement System
September 17, 2001
- Korosho to Conduct Surveys on Terminal Care in FY2002
September 17, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 17, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…